Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Hero Scientific Ltd. currently has 4 pending office actions in the Chemistry & Materials technology area. These actions are distributed across 4 distinct examiners and 4 distinct art units. This indicates a high level of diversification in the examination process, with each action being handled by a different examiner in a different art unit. Such a spread suggests that the company's intellectual property covers a broad spectrum of chemical technologies, requiring the management of four separate examination tracks.
WALLENHORST, MAUREEN is the busiest examiner for the company, overseeing 1 pending office action. Since there are 4 pending office actions and 4 distinct examiners, each examiner is handling exactly one action, meaning the workload is evenly distributed. The involvement of 4 distinct art units suggests that the company's chemistry-related filings cover a wide range of specialized technical categories. This prosecution profile requires the company to adapt to the specific examination standards of four different technical groups within the patent office simultaneously to address the 4 pending office actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WALLENHORST, MAUREEN | 1 | 78.9% | +5.8% |
| PEO, KARA M | 1 | 42.5% | +37.3% |
| SALVOZA, M FRANCO G | 1 | 68.4% | +30.0% |
| HINES, JANA A | 1 | 53.0% | +39.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17122594 | TESTING FOR PARTICULATES | HINES, JANA A | 26d overdue |
| 17801452 | TESTING FOR VIRUSES AND CELLULAR BIOMARKERS | SALVOZA, M FRANCO G | 34d |
| 18023607 | FILTRATION TESTING DEVICES | PEO, KARA M | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| 1777 | 1 |
| 1672 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18543136 | FILTRATION SAMPLING METHODS | WALLENHORST, MAUREEN | 1797 | §112DP | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18023607 | FILTRATION TESTING DEVICES | PEO, KARA M | 1777 | §103 | Non-Final OA | — | Pending | Feb 27, 2023 |
| 17801452 | TESTING FOR VIRUSES AND CELLULAR BIOMARKERS | SALVOZA, M FRANCO G | 1672 | §103 | Non-Final OA | 34d | Pending | Aug 22, 2022 |
| 17122594 | TESTING FOR PARTICULATES | HINES, JANA A | 1645 | §103 | Final Rejection | 26d overdue | Pending | Dec 15, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial